查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1478628

穿戴式註射器市場,佔有率,規模,趨勢,行業分析報告:依類型,技術,適應症,最終用途,地區,細分市場預測2024-2032 年

Wearable Injectors Market Share, Size, Trends, Industry Analysis Report, By Type (Off-body, On-body); By Technology; By Indication; By End Use; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球穿戴式注射器市場規模預計將達到 188.7 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

穿戴式注射器市場是由全球醫療基礎設施的進步所推動的。醫院、診所和家庭護理場所的設備改進將有助於將穿戴式註射器技術整合到醫療保健系統中，並改善患者護理的提供。遠距醫療和遠端監控的投資將進一步支持穿戴式註射器的使用並實現遠距患者管理。此外，改善的醫療基礎設施將改善醫療服務的可近性，並提高病患對穿戴式註射器的認識和接受度。隨著醫療保健系統滿足人口老化和慢性病增加的需求，穿戴式註射器正在成為一種便利的藥物管理解決方案。

穿戴式注射器市場也受到全球醫療保健系統日益重視以病人為中心的照護的影響。這種個人化的治療方法優先考慮患者的便利性、舒適性和自主性。穿戴式注射器允許患者在臨床環境之外自行給藥，使他們能夠更好地控制自己的醫療保健。透過提供連續的藥物傳遞和精確的劑量，這些設備可確保最佳的治療效果。穿戴式注射器讓患者在家中或外出時接受治療，提高患者滿意度和治療依從性，同時降低與醫院就診相關的醫療費用。

隨著穿戴式裝置在日常生活中的普及，將穿戴式解決方案納入醫療保健領域越來越被接受。穿戴式注射器提供方便、精確的藥物輸送，無縫地適應了這一趨勢。患者習慣使用穿戴式裝置進行健康監測，這使得他們更容易接受穿戴式注射器技術。穿戴式科技的進步，例如增強的感測器和連接功能，將改善穿戴式注射器的功能。與數位健康平台整合可以實現無縫數據收集和分析，以實現個人化醫療干預。

新興地區的市場擴張為穿戴式注射器市場帶來了巨大機會。由於經濟發展和醫療保健機會的改善，對先進醫療技術的需求不斷增加。穿戴式注射器為給藥提供了一種便捷的方法，並滿足新興市場醫療保健系統的需求。慢性病的流行和醫療費用的上漲等因素正在推動其採用。本地供應商和全球製造商之間的合作將加速技術的採用。

穿戴式注射器市場報告亮點

到 2023 年，由於便利性、易用性和可客製化設計的提高，貼裝市場佔據了很大的收入佔有率。

到 2023 年，由於可靠的藥物輸送、緊湊的設計和成本效益，彈簧加載細分市場佔據了主要的收入佔有率。

2023年，由於疾病負擔高、治療方案複雜以及治療依從性提高，腫瘤學佔了很大的銷售佔有率。

2023 年，由於工作流程簡化、治療依從性提高以及監管合規性提高，醫院和診所部門在銷售額中佔據很大佔有率。

由於醫療保健支出增加、人口老化加劇和政府舉措，預計亞太地區在預測期內將顯著增長。

市場遍佈全球，包括 Amgen Inc.、Becton、Dickinson and Company、CeQur SA、Medtronic plc、Roche Diagnostics International Ltd.、United Therapeutics Corporation、West Pharmaceutical Services, Inc. 和 Ypsomed Holding AG。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第四章全球穿戴式注射器市場洞察

  • 穿戴式注射器 - 業界快照
  • 穿戴式注射器市場動態
    • 驅動因素和機遇
      • 由於慢性病盛行率的增加，預計對該產品的需求將會增加。
      • 人口老化的加劇預計將推動穿戴式注射器市場的成長
    • 限制因素和課題
      • 開發成本高
  • PESTLE分析
  • 穿戴式注射器產業趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第五章全球穿戴式注射器市場：依科技分類

  • 主要發現
  • 介紹
  • 迴轉泵
  • 彈簧底座
  • 擴充電池
  • 馬達驅動
  • 其他

第六章全球穿戴式注射器市場：依類型

  • 主要發現
  • 介紹
  • 離開身體
  • 在身體上

第七章全球穿戴式注射器市場：依跡象分類

  • 主要發現
  • 介紹
  • 心血管疾病
  • 腫瘤學
  • 免疫缺陷
  • 感染
  • 自身免疫性疾病
  • 其他

第八章全球穿戴式注射器市場：依最終用途分類

  • 主要發現
  • 介紹
  • 醫院和診所
  • 居家護理
  • 其他

第九章全球穿戴式注射器市場：依地區

  • 主要發現
  • 介紹
    • 穿戴式注射器市場評估：依地區，2019-2032
  • 北美
    • 北美：依技術劃分，2019-2032
    • 北美：依最終用途分類，2019-2032
    • 北美：依類型劃分，2019-2032
    • 北美：依跡象顯示，2019-2032
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依技術分類，2019-2032
    • 歐洲：依最終用途分類，2019-2032
    • 歐洲：依類型劃分，2019-2032
    • 歐洲：依症狀分類，2019-2032
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依技術分類，2019-2032
    • 亞太地區：依最終用途分類，2019-2032
    • 亞太地區：依類型劃分，2019-2032
    • 亞太地區：依指標劃分，2019-2032
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印度尼西亞
    • 韓國
  • 中東/非洲
    • 中東和非洲：依技術分類，2019-2032
    • 中東和非洲：依最終用途分類，2019-2032
    • 中東和非洲：依類型劃分，2019-2032
    • 中東和非洲：依指標劃分，2019-2032
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯聯合酋長國
  • 拉丁美洲
    • 拉丁美洲：依技術分類，2019-2032
    • 拉丁美洲：依最終用途分類，2019-2032
    • 拉丁美洲：依類型劃分，2019-2032
    • 拉丁美洲：依指標劃分，2019-2032
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第十一章公司簡介

  • Amgen Inc
  • Becton, Dickinson and Company
  • CeQur SA
  • Debiotech SA
  • Elcam Medical
  • Enable Injections
  • Insulet Corporation
  • Medtronic plc
  • Roche Diagnostics International Ltd.
  • Sorrel Medical
  • Tandem Diabetes Care, Inc.
  • Unilife Corporation
  • United Therapeutics Corporation
  • West Pharmaceutical Services, Inc
  • Ypsomed Holding AG
Product Code: PM4842

The global Wearable Injectors market size is expected to reach USD 18.87 billion by 2032, according to a new study by Polaris Market Research. The report "Wearable Injectors Market Share, Size, Trends, Industry Analysis Report, By Type (Off-body, On-body); By Technology; By Indication; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The wearable injectors market is fueled by advancements in healthcare infrastructure globally. Improved facilities in hospitals, clinics, and home care settings facilitate the integration of wearable injector technology into healthcare systems, enhancing patient care delivery. Investments in telemedicine and remote monitoring further support wearable injector usage, enabling remote patient management. Additionally, better healthcare infrastructure enhances access to healthcare services, increasing patient awareness and acceptance of wearable injector devices. As healthcare systems adapt to address the needs of aging populations and rising chronic diseases, wearable injectors emerge as a convenient solution for medication administration.

The wearable injectors market is also influenced by a growing emphasis on patient-centric care in healthcare systems worldwide. These personalized treatment approaches prioritize patient convenience, comfort, and autonomy. Wearable injectors empower patients to self-administer medications outside clinical settings, enhancing control over their health management. By providing continuous drug delivery and precise dosage administration, these devices ensure optimal therapeutic outcomes. With the ability to receive treatment at home or while on the move, wearable injectors improve patient satisfaction and treatment adherence while reducing healthcare costs associated with hospital visits.

With the increasing prevalence of wearable devices in daily life, there's growing acceptance of incorporating wearable solutions into healthcare. Wearable injectors, providing convenient and precise drug delivery, align seamlessly with this trend. Patients' familiarity with using wearable devices for health monitoring makes them more receptive to wearable injector technology. Advancements in wearable tech, like enhanced sensors and connectivity features, improve the functionality of wearable injectors. Integration with digital health platforms enables seamless data collection and analysis for personalized healthcare interventions.

Market expansion in emerging regions presents significant opportunities for the wearable injectors market. With economic development and improved healthcare access, demand for advanced medical technologies rises. Wearable injectors offer a convenient method for medication administration, aligning with the needs of healthcare systems in emerging markets. Factors such as increasing chronic disease prevalence and healthcare expenditure drive adoption. Collaborations between local providers and global manufacturers facilitate technology introduction.

Wearable Injectors Market Report Highlights

In 2023, the on-body segment held significant revenue share owing to enhanced convenience, ease of use, and customizable design.

In 2023, the spring-based segment held significant revenue share owing to reliable drug delivery, compact design, and cost-effectiveness.

In 2023, the oncology held significant revenue share owing to high disease burden, complex treatment regimens, and improved treatment adherence.

In 2023, the hospitals and clinics segment held significant revenue share owing to streamlined workflow, enhanced treatment adherence, and regulatory compliance.

Asia-Pacific region is expected to experience significant growth during the forecast period due to increasing healthcare expenditure, growing aging population, and government initiatives.

The market is highly competitive owing to the existence of market players with a global presence, including Amgen Inc., Becton, Dickinson and Company, CeQur SA, Medtronic plc, Roche Diagnostics International Ltd., United Therapeutics Corporation, West Pharmaceutical Services, Inc., and Ypsomed Holding AG among others.

Polaris Market Research has segmented the Wearable Injectors market report based on type, technology, indication, end use, and region:

Wearable Injectors, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Off-body
  • On-body

Wearable Injectors, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Rotary pump
  • Spring-based
  • Expanding battery
  • Motor-driven
  • Others

Wearable Injectors, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Cardiovascular Diseases
  • Oncology
  • Immunodeficiency
  • Infectious Diseases
  • Autoimmune Diseases
  • Others

Wearable Injectors, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals and Clinics
  • Home Care
  • Others

Wearable Injectors, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Wearable Injectors Market Insights

  • 4.1. Wearable Injectors - Industry Snapshot
  • 4.2. Wearable Injectors Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of chronic diseases is projected to spur the product demand
      • 4.2.1.2. Growing aging population is expected to drive wearable injectors market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of development
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Wearable Injectors Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Wearable Injectors Market, by Technology

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • 5.3. Rotary pump
    • 5.3.1. Global Wearable Injectors Market, by Rotary pump, by Region, 2019-2032 (USD Billion)
  • 5.4. Spring-based
    • 5.4.1. Global Wearable Injectors Market, by Spring-based, by Region, 2019-2032 (USD Billion)
  • 5.5. Expanding battery
    • 5.5.1. Global Wearable Injectors Market, by Expanding battery, by Region, 2019-2032 (USD Billion)
  • 5.6. Motor-driven
    • 5.6.1. Global Wearable Injectors Market, by Motor-driven, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Wearable Injectors Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Wearable Injectors Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • 6.3. Off-body
    • 6.3.1. Global Wearable Injectors Market, by Off-body, by Region, 2019-2032 (USD Billion)
  • 6.4. On-body
    • 6.4.1. Global Wearable Injectors Market, by On-body, by Region, 2019-2032 (USD Billion)

7. Global Wearable Injectors Market, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 7.3. Cardiovascular Diseases
    • 7.3.1. Global Wearable Injectors Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Billion)
  • 7.4. Oncology
    • 7.4.1. Global Wearable Injectors Market, by Oncology, by Region, 2019-2032 (USD Billion)
  • 7.5. Immunodeficiency
    • 7.5.1. Global Wearable Injectors Market, by Immunodeficiency, by Region, 2019-2032 (USD Billion)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Wearable Injectors Market, by Infectious Diseases, by Region, 2019-2032 (USD Billion)
  • 7.7. Autoimmune Diseases
    • 7.7.1. Global Wearable Injectors Market, by Autoimmune Diseases, by Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Wearable Injectors Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Wearable Injectors Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • 8.3. Hospitals and Clinics
    • 8.3.1. Global Wearable Injectors Market, by Hospitals and Clinics, by Region, 2019-2032 (USD Billion)
  • 8.4. Home Care
    • 8.4.1. Global Wearable Injectors Market, by Home Care, by Region, 2019-2032 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Wearable Injectors Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Wearable Injectors Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Wearable Injectors Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 9.3. Wearable Injectors Market - North America
    • 9.3.1. North America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.3.2. North America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.3.3. North America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.3.4. North America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.5. Wearable Injectors Market - U.S.
      • 9.3.5.1. U.S.: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.5.2. U.S.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.5.3. U.S.: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.3.5.4. U.S.: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.3.6. Wearable Injectors Market - Canada
      • 9.3.6.1. Canada: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.3.6.2. Canada: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.3.6.3. Canada: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.3.6.4. Canada: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.4. Wearable Injectors Market - Europe
    • 9.4.1. Europe: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.4.2. Europe: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.4.3. Europe: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.4.4. Europe: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.5. Wearable Injectors Market - UK
      • 9.4.5.1. UK: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.5.2. UK: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.5.3. UK: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.5.4. UK: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.6. Wearable Injectors Market - France
      • 9.4.6.1. France: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.6.2. France: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.6.3. France: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.6.4. France: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.7. Wearable Injectors Market - Germany
      • 9.4.7.1. Germany: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.7.2. Germany: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.7.3. Germany: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.7.4. Germany: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.8. Wearable Injectors Market - Italy
      • 9.4.8.1. Italy: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.8.2. Italy: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.8.3. Italy: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.8.4. Italy: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.9. Wearable Injectors Market - Spain
      • 9.4.9.1. Spain: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.9.2. Spain: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.9.3. Spain: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.9.4. Spain: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.10. Wearable Injectors Market - Netherlands
      • 9.4.10.1. Netherlands: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.10.2. Netherlands: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.10.3. Netherlands: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.10.4. Netherlands: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.4.11. Wearable Injectors Market - Russia
      • 9.4.11.1. Russia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.4.11.2. Russia.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.4.11.3. Russia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.4.11.4. Russia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.5. Wearable Injectors Market - Asia Pacific
    • 9.5.1. Asia Pacific: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.5.2. Asia Pacific: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.5.3. Asia Pacific: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.5.4. Asia Pacific: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.5. Wearable Injectors Market - China
      • 9.5.5.1. China: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.5.2. China.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.5.3. China: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.5.4. China: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.6. Wearable Injectors Market - India
      • 9.5.6.1. India: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.6.2. India.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.6.3. India: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.6.4. India: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.7. Wearable Injectors Market - Japan
      • 9.5.7.1. Japan: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.7.2. Japan.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.7.3. Japan: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.7.4. Japan: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.8. Wearable Injectors Market - Malaysia
      • 9.5.8.1. Malaysia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.8.2. Malaysia.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.8.3. Malaysia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.8.4. Malaysia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.9. Wearable Injectors Market - Indonesia
      • 9.5.9.1. Indonesia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.9.2. Indonesia.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.9.3. Indonesia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.9.4. Indonesia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.5.10. Wearable Injectors Market - South Korea
      • 9.5.10.1. South Korea: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.5.10.2. South Korea.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.5.10.3. South Korea: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.5.10.4. South Korea: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.6. Wearable Injectors Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.6.2. Middle East & Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.6.3. Middle East & Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.6.4. Middle East & Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.5. Wearable Injectors Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.6. Wearable Injectors Market - South Africa
      • 9.6.6.1. South Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.6.2. South Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.6.3. South Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.6.4. South Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.7. Wearable Injectors Market - Israel
      • 9.6.7.1. Israel: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.7.2. Israel: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.7.3. Israel: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.7.4. Israel: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.6.8. Wearable Injectors Market - UAE
      • 9.6.8.1. UAE: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.6.8.2. UAE: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.6.8.3. UAE: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.6.8.4. UAE: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • 9.7. Wearable Injectors Market - Latin America
    • 9.7.1. Latin America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
    • 9.7.2. Latin America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
    • 9.7.3. Latin America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
    • 9.7.4. Latin America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.5. Wearable Injectors Market - Mexico
      • 9.7.5.1. Mexico: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.5.2. Mexico: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.5.3. Mexico: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.7.5.4. Mexico: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.6. Wearable Injectors Market - Brazil
      • 9.7.6.1. Brazil: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.6.2. Brazil: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.6.3. Brazil: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.7.6.4. Brazil: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
    • 9.7.7. Wearable Injectors Market - Argentina
      • 9.7.7.1. Argentina: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
      • 9.7.7.2. Argentina: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
      • 9.7.7.3. Argentina: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
      • 9.7.7.4. Argentina: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Amgen Inc
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Becton, Dickinson and Company
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. CeQur SA
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Debiotech SA
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Elcam Medical
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Enable Injections
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Insulet Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Medtronic plc
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Roche Diagnostics International Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Sorrel Medical
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Tandem Diabetes Care, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Unilife Corporation
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. United Therapeutics Corporation
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. West Pharmaceutical Services, Inc
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Ypsomed Holding AG
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables

  • Table 1 Global Wearable Injectors Market, by Technology, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Wearable Injectors Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Wearable Injectors Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Wearable Injectors Market, by End Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Wearable Injectors Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 6 North America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 7 North America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 8 North America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 9 North America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 10 U.S.: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 11 U.S.: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 13 U.S.: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Canada: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 15 Canada: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 16 Canada: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 17 Canada: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 18 Europe: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 19 Europe: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 20 Europe: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 21 Europe: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 22 Germany: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 23 Germany: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 25 Germany: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 France: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 27 France: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 28 France: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 29 France: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 30 UK: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 31 UK: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 32 UK: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 33 UK: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 34 Italy: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 35 Italy: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Italy: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 37 Italy: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Netherlands: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 39 Netherlands: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 40 Netherlands: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 41 Netherlands: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 42 Spain: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 43 Spain: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 44 Spain: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 Spain: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 46 Russia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 47 Russia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Russia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 49 Russia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Asia Pacific: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 51 Asia Pacific: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Asia Pacific: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 53 Asia Pacific: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 54 China: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 55 China: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 56 China: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 57 China: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 58 Japan: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 59 Japan: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Japan: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 61 Japan: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 India: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 63 India: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 64 India: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 65 India: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 66 Indonesia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 67 Indonesia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 68 Indonesia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 69 Indonesia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 70 Malaysia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 71 Malaysia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Malaysia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 73 Malaysia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 South Korea: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 75 South Korea: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 76 South Korea: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 77 South Korea: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 78 Latin America: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 79 Latin America: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 80 Latin America: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 81 Latin America: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 82 Brazil: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 83 Brazil: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Brazil: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 85 Brazil: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 86 Mexico: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 87 Mexico: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 88 Mexico: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 89 Mexico: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 90 Argentina: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 91 Argentina: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 92 Argentina: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 93 Argentina: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 94 Middle East & Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 95 Middle East & Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 96 Middle East & Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 97 Middle East & Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 98 UAE: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 99 UAE: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 100 UAE: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 101 UAE: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 102 Saudi Arabia: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 103 Saudi Arabia: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 104 Saudi Arabia: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 105 Saudi Arabia: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 106 South Africa: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 107 South Africa: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 108 South Africa: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 109 South Africa: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)
  • Table 110 Israel: Wearable Injectors Market, by Technology, 2019-2032 (USD Billion)
  • Table 111 Israel: Wearable Injectors Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Israel: Wearable Injectors Market, by Indication, 2019-2032 (USD Billion)
  • Table 113 Israel: Wearable Injectors Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Wearable Injectors Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End Use
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Technology
  • Figure 7. Global Wearable Injectors Market, by Technology, 2021 & 2030 (USD Billion)
  • Figure 8. Market by End Use
  • Figure 9. Global Wearable Injectors Market, by End Use, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Type
  • Figure 11. Global Wearable Injectors Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Indication
  • Figure 13. Global Wearable Injectors Market, by Indication, 2021 & 2030 (USD Billion)